Archit Organosys (BOM:524640) Total Equity: ₹762 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524640 Archit Organosys Ltd BOM:524640
65 GF Score
Price ₹55.57
GF Value ₹55.24
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Archit Organosys Total Equity?

Archit Organosys BOM:524640 -2.35% 65 Total Equity is ₹762 Mil as of Mar. 2026. GuruFocus rates BOM:524640 with a GF Score™ of 65/100 and a GF Value™ of ₹55.24 (Fairly Valued). The stock has 8 warning signs investors should review.

Archit Organosys's total equity for the quarter that ended in Mar. 2026 was ₹762 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Archit Organosys Total Equity Historical Data

* Premium members only.

The historical data trend for Archit Organosys's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Archit Organosys Total Equity Chart

Archit Organosys Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 518.93 617.76 641.46 692.06 762.33

Archit Organosys Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 692.06 0.00 727.81 0.00 762.33
BOM:524640
65GF Score
Archit Organosys Ltd BOM:524640
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Archit Organosys Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Archit Organosys's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1266.717-504.39
=762

Archit Organosys's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1266.717-504.39
=762

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹762 Mil mean?
Archit Organosys (BOM:524640) has a Total Equity of ₹762 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Archit Organosys and its competitors.
Is Archit Organosys' Total Equity too high?
Archit Organosys' current Total Equity is ₹762 Mil. Overall, Archit Organosys has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' Total Equity compare to DOW?
Archit Organosys' Total Equity of ₹762 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Archit Organosys and its competitors. Archit Organosys's current Total Equity is ₹762 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Fairly Valued. The stock's GF Value™ is ₹55.24, compared to a current price of ₹55.57 — trading 0.6% above its estimated fair value. The current Total Equity is ₹762 Mil. Archit Organosys' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current Total Equity is ₹762 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Archit Organosys (BOM:524640) Overvalued in 2026?

Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued. The current stock price of ₹55.57 is trading 0.6% above its estimated GF Value™ of ₹55.24. GuruFocus considers Archit Organosys to be Fairly Valued.

Key valuation signals for BOM:524640:

  • Total Equity: ₹762 Mil
  • GF Value™: ₹55.24 vs. price of ₹55.57 (0.6% above fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Archit Organosys Business Description

Address S. G. Highway, 9th Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, Ahmedabad, GJ, IND, 380054
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
65GF Score

Get the complete analysis for BOM:524640

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹55.57
Price
₹55.24
GF Value